Sinopharm
1099.HK
#2832
Rank
ยฃ4.61 B
Marketcap
ยฃ1.48
Share price
-3.25%
Change (1 day)
-21.97%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: ยฃ60.31 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is ยฃ60.31 Billion. In 2025 the company made a revenue of ยฃ60.31 Billion an increase over the revenue in the year 2024 that were of ยฃ58.75 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025ยฃ60.31 B2.65%
2024ยฃ58.75 B-5.1%
2023ยฃ61.91 B5.42%
2022ยฃ58.73 B-2.1%
2021ยฃ59.98 B16.85%
2020ยฃ51.33 B14.95%
2019ยฃ44.66 B21.52%
2018ยฃ36.75 B5.93%
2017ยฃ34.69 B27.22%
2016ยฃ27.26 B5.37%
2015ยฃ25.87 B9.14%
2014ยฃ23.71 B17.22%
2013ยฃ20.22 B25.94%
2012ยฃ16.06 B34.61%
2011ยฃ11.93 B55.34%
2010ยฃ7.68 B35.79%
2009ยฃ5.65 B37.56%
2008ยฃ4.11 B31.43%
2007ยฃ3.12 B40.26%
2006ยฃ2.23 B